Podcast Episodes
Back to Search
Pharmaceutical Executive Daily: Eli Lilly Presses U.K. Government to Raise NHS Drug Pricing
In today's Pharmaceutical Executive Daily, Eli Lilly presses the U.K. government to overhaul its NHS drug pricing framework as a condition of resumin…
1 month, 2 weeks ago
Pharmaceutical Executive Daily: Novartis Acquires Excellergy Inc.
In today's Pharmaceutical Executive Daily, Novartis agrees to acquire Excellergy for up to $2 billion to advance a next-generation anti-IgE therapy w…
1 month, 3 weeks ago
Pharmaceutical Executive Daily: Trump Administration Misses Deadline to Nominate Permanent CDC Director
In today's Pharmaceutical Executive Daily, the Trump administration misses a statutory deadline to nominate a permanent CDC director, leaving the age…
1 month, 3 weeks ago
Pharmaceutical Executive Daily: FDA Issues Warning Letter to ImmunityBio
In today's Pharmaceutical Executive Daily, the FDA issues a warning letter to ImmunityBio over misleading promotional claims about its bladder cancer…
1 month, 3 weeks ago
Pharmaceutical Executive Daily: Bayer Shares Drop After Inclusive Capital Offloads Remaining Stake
In today's Pharmaceutical Executive Daily, Bayer shares briefly dip after activist investor Inclusive Capital offloads its remaining stake at a loss,…
1 month, 3 weeks ago
Pharmaceutical Executive Daily: Pfizer Warns Shareholders to Reject Mini-Tender Offer
In today's Pharmaceutical Executive Daily, Pfizer warns shareholders to reject an unsolicited mini-tender offer from Tutanota LLC seeking to purchase…
1 month, 3 weeks ago
Pharmaceutical Executive Daily: FDA Approves Wegovy HD
In today's Pharmaceutical Executive Daily, Novartis agrees to acquire a pan-mutant-selective inhibitor from Synnovation Therapeutics in a deal worth …
2 months ago
The Ron Lanton Report: When Policy Becomes a Capital Event
The episode explores how regulatory signals across drug approvals, trade policy, AI governance, and drug pricing shape business strategy and investor…
2 months ago
Pharmaceutical Executive Daily: Analysis on TrumpRx List Pricing
In today's Pharmaceutical Executive Daily, a new analysis finds that TrumpRx is listing prices for roughly a third of its featured drugs higher than …
2 months ago
Pharmaceutical Executive Daily: Federal Judge Halts Vaccine Advisory Council Appointments
In today's Pharmaceutical Executive Daily, a federal judge blocks RFK Jr.'s reconstituted vaccine advisory committee and halts its policy changes, a …
2 months ago